VBI Vaccines
VBIV
#10650
Rank
S$2.4 M
Marketcap
S$0.08395
Share price
0.00%
Change (1 day)
-89.69%
Change (1 year)

EPS for VBI Vaccines (VBIV)

EPS in 2024 (TTM): S-$13.65

According to VBI Vaccines 's latest financial reports the company's current EPS (TTM) is S-$13.04. In 2022 the company made an earnings per share (EPS) of S-$16.97 a decrease over its 2021 EPS that were of S-$10.41.

EPS history for VBI Vaccines from 1997 to 2024

Annual EPS

Year EPS Change
2024 (TTM)S-$13.65
2022S-$16.9762.96%
2021S-$10.4128.57%
2020S-$8.10-54.35%
2019S-$17.74-52.58%
2018S-$37.4110.23%
2017S-$33.9414.29%
2016S-$29.70-62.8%
2015S-$79.8390.68%
2014S-$41.87-7.95%
2013S-$45.49-57.97%
2012S-$108.23-78%
2011S-$492.043151.47%
2010S-$15.1323.87%
2009S-$12.22-18.48%
2008S-$14.9912.08%
2007S-$13.37-49.47%
2006S-$26.46
2005N/A-100%
2004S-$11.7611.94%
2003S-$10.51-81.89%
2002S-$58.03196.44%
2001S-$19.5884.33%
2000S-$10.62-65.37%
1999S-$30.67-29.45%
1998S-$43.4729.61%
1997S-$33.54

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Onconova Therapeutics
ONTX
S-$1.22-90.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Curis
CRIS
S-$4.72-63.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Myriad Genetics
MYGN
S-$5.57-57.30%๐Ÿ‡บ๐Ÿ‡ธ USA